"NRC Research Institute is a dedicated clinical research and development facility located in Orange, California. Our mission is to obtain quality research data in order to advance safe and effective therapeutics to the marketplace. We have worked with the top globally recognized pharmaceutical and bio-tech companies on the development of both FDA-approved and investigational medications. Participate in a clinical trial today to help advance future medical treatments tomorrow!"

During the past decade, NRC Research Institute conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 59 clinical trials were completed, i.e. on average, 88.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 31 clinical trials were completed. i.e. 155% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NRC Research Institute" #1 sponsor was "Sunovion" with 10 trials, followed by "Pfizer" with 9 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 8 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NRC Research Institute" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "NRC Research Institute" are "Schizophrenia" (29 trials), "Depressive Disorder, Major" (11 trials), "Major Depressive Disorder" (7 trials), "Autism" (5 trials) and "Bipolar I Disorder" (5 trials). Many other conditions were trialed in "NRC Research Institute" in a lesser frequency.

Most popular intervention types in "NRC Research Institute" are "Drug" (101 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Rapastinel" (5 trials), "Xanomeline and Trospium Chloride Capsules" (5 trials), "CM-AT" (4 trials) and "Lurasidone" (4 trials). Other intervention names were less common.

The vast majority of trials in "NRC Research Institute" are 98 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "NRC Research Institute". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 71 completed trials in NRC Research Institute, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in NRC Research Institute, 7 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".